We thought to determine the utility of the microfluidic digital PCR technique for assessment of BRAF and TERT mutations in routinely processed thyroid tissue samples, with the aim to provide ‘on-time’ information for the clinical thyroidologists regarding possible treatment options, as well as data informing the prognosis in patients with thyroid cancer. Here, BRAF is linked to thyroid cancer.